Showing results (1181-1190 of 1,485) with videos related to

Sort By:
Pageof 149
Movement Disorders : Official Journal of the Movement Disorder Society|September 9, 2005
Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic dietJennifer R L Friedman, Elizabeth A Thiele, Dong Wang, et al.
Gynecologic Oncology|June 10, 2025
Cytology-negative, non-myoinvasive stage IC serous endometrial cancer: Assessment of adjuvant chemotherapy omissionKoji Matsuo, Emmeline L Friedman, Matthew W Lee, et al.
Journal of Hepatology|July 10, 2009
Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infectionYonghong Li, Monica Chang, Olivia Abar, et al.
Plos One|March 4, 2014
Pediatric malignancies, treatment outcomes and abandonment of pediatric cancer treatment in ZambiaJeremy S Slone, Catherine Chunda-Liyoka, Marta Perez, et al.
Gastroenterology|June 3, 2008
The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver diseaseLuca Miele, Gary Beale, Gillian Patman, et al.
Cells|October 15, 2024
Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate CellsKavita Prasad, Dipankar Bhattacharya, Shams Gamal Eldin Shams, et al.
The American Journal of Hospice & Palliative Care|May 10, 2022
Effects of a Web-Based Pediatric Oncology Legacy Intervention on the Coping of Children With CancerEunji Cho, Mary S Dietrich, Debra L Friedman, et al.
Circulation|November 5, 1999
Identification of risk factors in hypertensive patients: contribution of randomized controlled trials through an individual patient databaseF Gueyffier, J P Boissel, S Pocock, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 12, 2009
Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258Yuqing Liu, Xiao Ming Wen, Eric Lik Hang Lui, et al.
The New England Journal of Medicine|March 21, 1991
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression TrialD S Echt, P R Liebson, L B Mitchell, et al.
Pageof 149